Immediate Impact
1 from Science/Nature 78 standout
Citing Papers
Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522
2024 Standout
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression
2024 Standout
Works of Thomas H. Openshaw being referenced
Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: American Society of Clinical Oncology Endorsement of Cancer Care Ontario Guideline Recommendations
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Thomas H. Openshaw | 104 | 97 | 25 | 37 | 12 | 183 | |
| Lotte Holm Land | 99 | 200 | 17 | 53 | 11 | 297 | |
| Bruna Salani Mota | 142 | 102 | 26 | 36 | 19 | 277 | |
| Mathias Warm | 71 | 86 | 8 | 27 | 20 | 177 | |
| Jackie Charman | 85 | 148 | 12 | 108 | 16 | 274 | |
| Rebeca Mondéjar | 83 | 133 | 14 | 91 | 16 | 228 | |
| A.B.G. Kwast | 131 | 161 | 21 | 50 | 13 | 279 | |
| Grace Hsu | 60 | 74 | 19 | 67 | 13 | 256 | |
| Kwang Hyun Yoon | 93 | 117 | 9 | 36 | 16 | 255 | |
| Kathryn Edmiston | 60 | 129 | 24 | 31 | 13 | 270 | |
| Catherine Bresson | 43 | 76 | 21 | 67 | 19 | 199 |
All Works
Login with ORCID to disown or claim papers
Loading papers...